glp-1 compounders Despite FDA ruling, compounded GLP-1s are still giving Novo and Lilly headaches on the market Compounded GLP-1s: Why doctors worry

Want to hear more from an expert

10.1016/j.brainres.2005.03.011 3 AgersoH.JensenL

Mistake 2: attributing transition spikes to the new dose You increase from 5 mg to 7.5 mg of tirzepatide and experience severe nausea

Instead of stopping entirely, they reduce to the lowest effective dose and maintain it long-term

Key topics to discuss include: Your fertility plans and timeline : If you are planning to conceive in the near future, your healthcare provider can advise on the appropriate timing for discontinuing GLP-1 medication

Athletes are not good candidates if: They are chronically under-fueling They have a history of an eating disorder or disordered eating If their nutrition, recovery, and other key lifestyle habits aren't yet well established Athletes may benefit, alongside comprehensive nutrition and medical care, if: They're experiencing overweight/obesity or metabolic disease Have significant inflammation or other medical conditions Have experienced certain peri/post-menopausal changes Even if you're a good candidate for GLP-1 meds, there are still potential risks